Suite 1300
Salt Lake City, UT 84111
Block-1 3rd Floor, Perungudi Bypass Rd, Perungudi,
Chennai - 600096
MGR Main Rd,
Perungudi, Chennai - 600096
Villupuram,
Tamil Nadu – 605602
Medicaid Denial Management
State-Specific Medicaid Denial
Recovery at Scale
Medicaid denial management with state-specific playbooks across all 50 programs — payer-trained appeals specialists, coverage and medical necessity playbooks, and the operational discipline to recover what other vendors write off after first rejection.
75%+
Appeal overturn
ALL 50 STATE
Playbooks
< 9%
Medicaid denial rate
The Reality
Why Medicaid Denials Drain LTC Pharmacy Revenue Faster Than Any Other Payer Class?
State-Specific Appeal Processes
Every state Medicaid program runs its own appeal timeline, documentation requirement, and adjudication pathway. A successful appeal protocol in Texas may be procedurally wrong in Pennsylvania, and missing the state-specific window means the claim is permanently lost.
High Denial Volume on LTC Population
Medicaid denial rates on LTC populations run 22–30% — substantially higher than any other pharmacy segment. Atypicals, behavioral health drugs, and high-cost specialty medications used in LTC settings get denied at high rates and require dedicated appeal infrastructure
MCO Layered on State Rules
Medicaid managed care now covers the majority of LTC populations in most states. MCO denials add a second layer of payer-specific appeal rules on top of state Medicaid pathways. Each MCO carrier has its own protocols, escalation paths, and external review options.
Documentation Burden
Medicaid appeals require clinical documentation, prior treatment history, medical necessity justification, and prescriber attestation. LTC pharmacy billing teams not staffed with clinical literacy lose appeals on documentation gaps, not denial merits.
Aged Denial Write-Off Risk
LTC pharmacies routinely write off Medicaid denials aged beyond 60–90 days because the recovery work isn't economical for in-house teams. The cumulative effect on margin is severe, especially in states with restrictive Medicaid formularies.
External Review Underutilization
State Medicaid programs and MCO carriers offer external review pathways that overturn first-level denial decisions at rates above 60%. Most LTC pharmacies don't have the appeals infrastructure to pursue external review systematically.
Recent Client Results
Proof From The Field
75%+
Medicaid Appeal Overturn
Rate
< 9%
Net Medicaid Denial
Rate
All 50
State Medicaid Appeal
Playbooks
How we support you
End-to-End Medicaid Denial Recovery
Denial Triage
Root-cause analysis on receipt
- Denial reason categorization (CARC/RARC)
- State Medicaid vs. MCO routing decision
- Coverage vs. medical necessity vs. coding split
- Resubmission vs. appeal pathway selection
- Appeal window calculation by state and payer
- Documentation requirement assembly
Appeal Preparation
State and payer-specific protocols
- State-specific appeal letter generation
- Clinical evidence packet assembly
- Prescriber attestation coordination
- Medical necessity justification per payer policy
- Prior treatment history documentation
- External review pathway escalation
Aged Denial Recovery
Sweep for previously written-off denials
- Six-month historical denial audit
- Recovery prioritization by dollar value
- Aged appeal pathway re-opening
- Secondary payer billing on COB-eligible claims
- Patient pay conversion on uncoverable denials
- Write-off prevention reporting
Financial impact and performance
What these improvements mean in Dollars?
Improvement Area
Estimated Annual Impact
Medicaid Denial Reduction (28% → 9%)
$400K – $1.4M annually in recovered claims
Appeal Overturn Recovery (first 6 months)
$300K – $1.2M in one-time aged denial capture
MCO Appeal Recovery
$200K – $700K annually in MCO carrier-specific recovery
External Review Capture
$100K – $400K annually in second-level overturn revenue
Aged Denial Write-Off Prevention
$150K – $500K annually in retained revenue
Cycle Time Reduction (94 → 38 days)
$200K – $700K in freed working capital
Staffing Cost Reduction
$200K – $500K annually
Performance Targets vs. Industry Benchmark
Performance Metric
Industry Benchmark
AnnexMed Target
Medicaid Appeal Overturn Rate
LTC industry avg: 38–50%
75%+
Net Medicaid Denial Rate
LTC industry avg: 22–30%
< 9%
MCO Appeal Overturn Rate
LTC industry avg: 35–48%
70%+
State Medicaid Coverage
Most vendors cover 5–15 states
All 50 states
Aged Denial Recovery Rate
LTC industry avg: 18–28%
60%+
External Review Utilization
LTC industry: rarely pursued
Standard practice
Denial Recovery Cycle Time
LTC industry avg: 80–120 days
< 40 days
Appeal Documentation Completeness
LTC industry avg: 75–84%
98%+
Why Annexmed?
In-House vs. AnnexMed Partnership
In-House / Traditional
AnnexMed Partnership
State Appeal Coverage
Strong on 2–3 home states; weak elsewhere
All 50 state-specific appeal playbooks pre-built and maintained
Appeal Overturn Rate
38–50% on first-level appeals
75%+ overturn on first-level appeals with clinical documentation
MCO Appeals
Limited carrier coverage; many denials written off
All major national and regional MCO carriers covered systematically
Aged Denial Treatment
Aged > 90 days routinely written off
Six-month historical sweep with recovery prioritization
External Review Pursuit
Rarely used; second-level overturns missed
Standard escalation pathway with state-specific protocols
Clinical Documentation
Limited prescriber engagement; appeals lost on documentation
Clinical evidence packets assembled by appeals-trained staff
Recovery Cycle Time
80–120 days from denial to resolution
Under 40 days from denial to resolution
Cost to Operate
$60K–$95K per FTE; high turnover on appeals work
30–40% lower with no hiring, attrition, or training overhead
Real cost example: Multi-state LTC pharmacy with $48M annual revenue serving 6 states
In-House: $520,000 annual cost (6 FTE on Medicaid denial work + clinical coordinator + software) + estimated $1.6M annual exposure (lost appeals, aged write-offs, MCO denial absorption, external review underutilization). AnnexMed: $310,000 annual partnership fee + projected $2.3M annual financial benefit (denial reduction, appeal overturn, aged denial recovery, MCO appeal capture) = net annual financial benefit of approximately +$2.0M per year, plus working capital acceleration.
Technology
Powered by proprietary AI & analytics
AnnexMed’s technology stack was built for payer-specific operational demands, not adapted from provider-side billing tools. Risk adjustment accuracy, payment integrity, and credentialing compliance each require different data models, workflow logic, and reporting architectures than provider RCM. Our platform reflects that.
AI Agents & Automation
AI Agents & Intelligent Automation deploys autonomous AI agents across the full revenue cycle, automating eligibility verification, prior authorization, claims processing, payment posting, and denial management at hospital scale and speed.
Data & Analytics Platform
Data & Analytics Platform delivers real-time Power BI dashboards built for hospital executive visibility, including system-wide KPIs, service line performance, payer analysis, productivity, financial forecasting, and national benchmarking insights.
Intelligent AR Management
Intelligent AR Management handles A/R follow-up at hospital scale with intelligent worklists prioritized by dollar value and aging, payer-specific follow-up rules, automated escalation for high-value accounts, and full accountability for every claim.
Computer Assisted Coding
Computer Assisted Coding orchestrates hospital coding operation, intelligent chart assignment by service line, TAT tracking with SLA monitoring, quality audits with accuracy scoring, and coder performance management at enterprise scale.
Together, these platforms create a fully instrumented RCM operation where nothing falls through the cracks. You don’t interact with these systems directly, but the results they enable show up directly in your financial performance.
Ready to Recover the Medicaid Denials Your LTC Pharmacy Has Been Writing Off?
Trusted by 100+ Healthcare Providers | AAPC, AHIMA & AAHAM Certified | SOC 2 Type II | HIPAA Compliant
Payer client outcomes
$15M–$40M
Risk
Adjustment
$18M–$50M
Payment
Integrity
6 Weeks
Credentialing Clearance
$15M–$50M+
Revenue
Impact
Case Studies
See the impact we deliver
Discover how AnnexMed reduces denials, accelerates reimbursements, and strengthens financial performance. Backed by measurable outcomes and proven RCM expertise, we deliver operational excellence, revenue stability, and sustainable growth you can trust.
Client Voices
See how our clients succeed
Proven RCM expertise. Delivered at scale.
For over 20 years, AnnexMed has delivered RCM solutions nationwide, combining expert billing, coding, and AR support to drive measurable results and growth.
- 20+ years of proven healthcare RCM experience
- 2,000+ professionals supporting billing, coding & AR
- 500+ certified coders across multiple specialties
- 99%+ compliance with HIPAA and security standards
- All 50 states served with consistent, scalable operations
